XBiotech Data Shows Effective Anti-Virus Activity for True Human Antibodies in Its Candidate Influenza-COVID-19 Therapeutic Cocktail - Seite 3

Nachrichtenquelle: globenewswire
19.11.2020, 14:15  |  181   |  0   |   

Diesen Artikel teilen
Seite 3 von 2
Wertpapier


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

XBiotech Data Shows Effective Anti-Virus Activity for True Human Antibodies in Its Candidate Influenza-COVID-19 Therapeutic Cocktail - Seite 3 Candidate Therapy for Flu+Covid-19 Co-infection Shows Potent Anti-Viral PotentialAUSTIN, Texas, Nov. 19, 2020 (GLOBE NEWSWIRE) - XBiotech Inc. (NASDAQ: XBIT) announced today new data for its breakthrough candidate therapy for treating infections …

Community

Nachrichten des Autors

Titel
Bitfarms Announces Purchase Agreement for 48,000 MicroBT Miners to Expand Hash Rate Capacity by ...
Hexagon Purus signs Joint Venture agreements with CIMC Enric for China and Southeast Asia, the ...
Die Aktionäre von Novartis heissen an der Generalversammlung alle Anträge des Verwaltungsrats gut
Algernon Pharmaceuticals Announces Private Placement
Plug Power and Universal Hydrogen Expand Partnership to Include Investment and Global Green ...
REPEAT -- Clean Power Capital Corp.: PowerTap Partners With Carbonomics to Maximize Carbon Credit Opportunities
Hunter Technology Market Testing Pilot April Launch
DMG is Selected by Ecopwrs LLC for Developing and Managing its Bitcoin mining operations in the USA
BIGG Digital Assets Inc. Subsidiary Netcoins Announces Daily Revenue Grew 54% Month over Month in ...(2) 
Shez Partovi to succeed Jeroen Tas as Philips’ Chief Innovation & Strategy Officer
Titel
Emerging Markets Report: One + One = Three
TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Carving Out New Market Niche
TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Brings ‘Same Format, Different Ingredients’ Model to Smoking Market
InflaRx Announces Pricing of $75 Million Public Offering of Common Shares and One-Year Warrants
Orocobre Limited Reports H1 FY21 Results
Valoe Corporation’s Financial Statement Release 2020 
SeaBird Exploration Plc: Information relating to the distribution of shares in Green Minerals AS
Royal Dutch Shell advance notice of Q1 2021 results announcement
Bitfarms Announces Purchase Agreement for 48,000 MicroBT Miners to Expand Hash Rate Capacity by ...
InflaRx Announces Proposed Offering of Common Shares and One-Year Warrants
Titel
Spineway Expansion in Asia
Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of ...
Ocugen Inc. Announces $23 Million Registered Direct Offering of Common Stock Priced at a Premium to ...
SPINEWAY: NEW BUSINESS AGREEMENT DEDICATED TO 3D INNOVATION
American Lithium Reaches Agreement to Acquire Plateau Energy Metals and Consolidate ...
REPEAT --TAAT E-Commerce Launching Wednesday February 17, Availing Original, Smooth, and Menthol to ...
Emerging Markets Report: One + One = Three
21Shares Launches The World’s First Polkadot ETP
Ocugen, Inc. Announces Closing of $23 Million Registered Direct Offering of Common Stock
EHang Responds to Deceptive Wolfpack Research Report
Titel
Spineway Expansion in Asia
AgraFlora Organics Expects to Enter Edibles Market in Q1
HyperSolar Changes Company Name to SunHydrogen
Halo Announces Pricing of Overnight Marketed Offering of Units
WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020
Bombardier unterzeichnet Vertrag für weitere zehn Jahre Betrieb und Wartung des automatischen ...
Ocugen and Bharat Biotech to Co-Develop COVAXIN, a Whole-Virion Inactivated COVID-19 Vaccine, for ...
HyperSolar To Begin Production on 100 Hydrogen Generation Units for Demonstration
Mateon Expands its COVID-19 Therapeutic Program to include Artemisinin
Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of ...

COMMUNITY

ZeitTitel
30.01.21
70
XBIOTECH INC - Eine neue Novartis?
30.01.21
6
XBiotech / Human Antikörper / COVID 19